These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 11399105)

  • 1. Gradual micronutrient accumulation and depletion in Alzheimer's disease.
    Johnson S
    Med Hypotheses; 2001 Jun; 56(6):595-7. PubMed ID: 11399105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis.
    Johnson S
    Med Hypotheses; 2000 Sep; 55(3):239-41. PubMed ID: 10985916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease?
    Johnson S
    Med Hypotheses; 2001 May; 56(5):641-5. PubMed ID: 11388783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
    Gómez M; Esparza JL; Cabré M; García T; Domingo JL
    Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein and antioxidant enzymes in Long-Evans Cinnamon rats treated with zinc.
    Medici V; Santon A; Sturniolo GC; D'Incà R; Giannetto S; Albergoni V; Irato P
    Arch Toxicol; 2002 Sep; 76(9):509-16. PubMed ID: 12242608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and gender.
    Wills NK; Ramanujam VM; Kalariya N; Lewis JR; van Kuijk FJ
    Exp Eye Res; 2008 Aug; 87(2):80-8. PubMed ID: 18579132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
    Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI
    J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?
    Johnson S
    Med Hypotheses; 2001 Feb; 56(2):171-3. PubMed ID: 11425282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multifaceted and widespread pathology of magnesium deficiency.
    Johnson S
    Med Hypotheses; 2001 Feb; 56(2):163-70. PubMed ID: 11425281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer disease and calcium].
    Fujita T
    Clin Calcium; 2004 Jan; 14(1):103-5. PubMed ID: 15576964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant enzymes activity and lipid peroxidation in liver and kidney of rats exposed to cadmium and ethanol.
    Jurczuk M; Brzóska MM; Moniuszko-Jakoniuk J; Gałazyn-Sidorczuk M; Kulikowska-Karpińska E
    Food Chem Toxicol; 2004 Mar; 42(3):429-38. PubMed ID: 14871584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    El Khoury J; Luster AD
    Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal homeostasis in Alzheimer's disease.
    White AR; Barnham KJ; Bush AI
    Expert Rev Neurother; 2006 May; 6(5):711-22. PubMed ID: 16734519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
    Smith JL; Xiong S; Markesbery WR; Lovell MA
    Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.